Skip to main content
Top
Published in: Journal of General Internal Medicine 5/2020

01-05-2020 | Hepatitis C | Concise Research Report

Improving Hepatitis C Screening Rates in an Ambulatory Clinic: an Observational Study

Authors: Rajesh Essrani, MD, Eric Nellis, MD, Hiral Shah, MD

Published in: Journal of General Internal Medicine | Issue 5/2020

Login to get access

Excerpt

Hepatitis C virus (HCV) is a liver disease that can progress to hepatic fibrosis, cirrhosis, and hepatocellular carcinoma. Risk factors for HCV include people born between 1945 and 1965, hemodialysis, history of Intravenous drug abuse (IVDA), persistent elevation in alanine transaminase without a known cause, human immunodeficiency virus (HIV) infection, and patients who received clotting factors before 1987 or blood products before 1992. Therefore, the CDC and USPSTF recommends HCV screening for all those born between 1945 and 1965 (the baby boomer population) and those with other risk factors.1,2
Literature
1.
go back to reference Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, Jewett A, Baack B, Rein DB, Patel N, Alter M, Yartel A, Ward JW, Centers for Disease C, Prevention: Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports. 2012, 61:1–32.PubMed Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, Jewett A, Baack B, Rein DB, Patel N, Alter M, Yartel A, Ward JW, Centers for Disease C, Prevention: Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports. 2012, 61:1–32.PubMed
3.
go back to reference Spradling PR, Rupp L, Moorman AC, Lu M, Teshale EH, Gordon SC, Nakasato C, Boscarino JA, Henkle EM, Nerenz DR, Denniston MM, Holmberg SD: Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012, 55:1047–1055. https://doi.org/10.1093/cid/cis616 CrossRef Spradling PR, Rupp L, Moorman AC, Lu M, Teshale EH, Gordon SC, Nakasato C, Boscarino JA, Henkle EM, Nerenz DR, Denniston MM, Holmberg SD: Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012, 55:1047–1055. https://​doi.​org/​10.​1093/​cid/​cis616 CrossRef
Metadata
Title
Improving Hepatitis C Screening Rates in an Ambulatory Clinic: an Observational Study
Authors
Rajesh Essrani, MD
Eric Nellis, MD
Hiral Shah, MD
Publication date
01-05-2020
Publisher
Springer International Publishing
Keyword
Hepatitis C
Published in
Journal of General Internal Medicine / Issue 5/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05363-2

Other articles of this Issue 5/2020

Journal of General Internal Medicine 5/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.